EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

On the Verge of the 3000th Publication: Reflections on Deceptions, Successes and Perspectives

Erik De Clercq iD

Molecules · 20.08.2026 · 31 (16) · 2896

DOI: 10.3390/molecules31162896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 20.08.2026. Verfasst von Erik De Clercq. Beteiligte Einrichtung: Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, B-3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Antiviral Agents, Viruses. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A lifelong career devoted to the development of specific antiviral agents eventually yielded, besides (almost) 3000 publications, about ten antiviral compounds that were approved and marketed as antiviral drugs, i.e., DHPA (Duviragel®), BVDU (Zostex®, Mevir®, Brivir®…), VACV (Zelitrex®, Valtrex®), d4T (Stavudine®), emivirine (Coactinon®), rilpivirine (Edurant®), HPMPC (Vistide®), PMEA (Hepsera®), tenofovir (Viread®) and AMD-3100 (Mozobil®), with the latter as a hematopoietic stem cell mobilizer. The targeted viruses for these compounds were herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), human immunodeficiency virus (HIV), and hepatitis B virus (HBV). For other viruses, such as filo-, rhabdo-, arena-, myxo-, polyoma- and papillomaviruses, strategies have been elaborated that should facilitate future developments of antiviral drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsVirusesHumansHistory, 20th CenturyHistory, 21st CenturyBelgiumInterferonsAnimalsVirus Diseases

Stichwörter der Autor:innen

AMD-3100BVDUDHPAHPMPCPMEAVACVd4Temivirinerilpivirinetenofovir

Substanzen

Antiviral AgentsInterferons

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, B-3000 Leuven, Belgium.

ORCID-Profile: Erik De Clercq

Zitieren

APA

De Clercq, E. (2026). On the Verge of the 3000th Publication: Reflections on Deceptions, Successes and Perspectives. Molecules, 31(16), 2896. https://doi.org/10.3390/molecules31162896

Vancouver

De Clercq E. On the Verge of the 3000th Publication: Reflections on Deceptions, Successes and Perspectives. Molecules. 2026;31(16):2896. doi:10.3390/molecules31162896

BibTeX
@article{DeClercq2026,
  author = {De Clercq, Erik},
  title = {On the Verge of the 3000th Publication: Reflections on Deceptions, Successes and Perspectives},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {16},
  pages = {2896},
  doi = {10.3390/molecules31162896}
}
Kostenlos starten →